KCTD14 and breast cancer: Immunohistochemical EliVision method was used to detect the expressions of KCTD14 and FUNDC2 in 82 luminal subtype breast cancer tissues, 58 TNBC paraffin tissue samples and 33 nontumor benign lesions (Figure 3A,B).